HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

David G Beer Selected Research

polyacrylamide

7/2004The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis.
3/2004Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
3/2004Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.
11/2003Protein profiles associated with survival in lung adenocarcinoma.
4/2003Proteomic analysis of eIF-5A in lung adenocarcinomas.
4/2002Discordant protein and mRNA expression in lung adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


David G Beer Research Topics

Disease

76Neoplasms (Cancer)
09/2015 - 04/2002
57Adenocarcinoma
09/2015 - 04/2002
25Lung Neoplasms (Lung Cancer)
09/2015 - 12/2002
10Barrett Esophagus (Barrett's Esophagus)
09/2015 - 03/2003
9Metaplasia
07/2014 - 01/2004
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 11/2004
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2012 - 03/2003
4Neoplasm Metastasis (Metastasis)
09/2015 - 08/2005
4Carcinoma (Carcinomatosis)
01/2014 - 03/2003
4Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 01/2008
2Breast Neoplasms (Breast Cancer)
07/2015 - 01/2015
2Retinoblastoma (Glioblastoma, Retinal)
01/2015 - 08/2012
2Gastroesophageal Reflux (GERD)
05/2004 - 07/2003
1Aneuploidy (Aneuploid)
09/2015
1Diabetes Mellitus
07/2015
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2015
1Cardiovascular Diseases (Cardiovascular Disease)
07/2015
1Experimental Melanoma
01/2015
1B-Cell Leukemia (Leukemia, B Cell)
01/2015
1Leukemia
01/2015
1Hematologic Neoplasms (Hematological Malignancy)
01/2014
1Colorectal Neoplasms (Colorectal Cancer)
09/2012
1Ovarian Neoplasms (Ovarian Cancer)
08/2011

Drug/Important Bio-Agent (IBA)

22Messenger RNA (mRNA)IBA
01/2015 - 04/2002
19Aminocaproic Acids (EAC)FDA LinkGeneric
09/2015 - 07/2003
18Adenocarcinoma of lungIBA
01/2015 - 07/2002
12DNA (Deoxyribonucleic Acid)IBA
07/2014 - 05/2003
10Proteins (Proteins, Gene)IBA
09/2015 - 04/2002
9Protein Isoforms (Isoforms)IBA
09/2015 - 07/2002
9Biological Markers (Surrogate Marker)IBA
06/2014 - 07/2002
7Phosphotransferases (Kinase)IBA
01/2015 - 07/2003
6polyacrylamideIBA
07/2004 - 04/2002
5MicroRNAs (MicroRNA)IBA
01/2015 - 07/2009
5Transcription Factors (Transcription Factor)IBA
09/2012 - 12/2007
4Cisplatin (Platino)FDA LinkGeneric
08/2015 - 02/2008
4Complementary DNA (cDNA)IBA
08/2005 - 09/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2015 - 03/2004
3RNA (Ribonucleic Acid)IBA
07/2015 - 01/2005
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
04/2015 - 02/2011
3Small Interfering RNA (siRNA)IBA
01/2015 - 02/2008
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2014 - 05/2004
3Carrier Proteins (Binding Protein)IBA
03/2012 - 03/2004
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2011 - 07/2008
3NF-kappa B (NF-kB)IBA
04/2010 - 08/2005
3NADPH Oxidase (NAD(P)H oxidase)IBA
01/2008 - 07/2006
2Fluorouracil (Carac)FDA LinkGeneric
08/2015 - 04/2010
2Cyclin D1IBA
01/2015 - 08/2012
2Protein Kinases (Protein Kinase)IBA
01/2015 - 08/2012
2AntibodiesIBA
01/2015 - 04/2007
2AntigensIBA
01/2015 - 09/2004
2PeptidesIBA
06/2014 - 04/2007
2Checkpoint kinase 1IBA
03/2014 - 12/2013
2pemetrexed (MTA)FDA Link
12/2013 - 02/2011
2erlotinib (CP 358,774)FDA Link
06/2011 - 03/2010
2Tyrosine (L-Tyrosine)FDA Link
06/2011 - 07/2003
2Vitamin DFDA LinkGeneric
02/2011 - 03/2010
2SeleniumIBA
04/2010 - 03/2004
2AutoantibodiesIBA
11/2008 - 04/2007
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2004 - 05/2003
1Insulin-Like Growth Factor Binding ProteinsIBA
09/2015
1EnzymesIBA
09/2015
1Pyruvate KinaseIBA
09/2015
1phosphoribosylaminoimidazole carboxylaseIBA
09/2015
1phosphoribosylaminoimidazole- succinocarboxamide synthetaseIBA
09/2015
1purineIBA
09/2015
1OsteopontinIBA
09/2015
1matrigelIBA
08/2015
1HydrogelIBA
07/2015
1Platelet-Derived Growth FactorIBA
07/2015
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2015
1GuanosineIBA
01/2015
1Monoclonal AntibodiesIBA
01/2015
1Estrogens (Estrogen)FDA Link
01/2015
1Laminin ReceptorsIBA
01/2015
1TamoxifenFDA LinkGeneric
01/2015
1Carbon MonoxideIBA
12/2014
1transglutaminase 2IBA
06/2014
1((1S,2S,4R)- 4- (4- ((1S)- 2,3- dihydro- 1H- inden- 1- ylamino)- 7H- pyrrolo(2,3- d)pyrimidin- 7- yl)- 2- hydroxycyclopentyl)methyl sulphamateIBA
02/2014
1LigasesIBA
02/2014
1Cytoskeletal ProteinsIBA
01/2014
1telomerase RNA (bTR)IBA
01/2014
1A-Form DNA (A-DNA)IBA
11/2013
1Serum-Free Culture MediaIBA
04/2013
1ProteomeIBA
01/2013
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2013
1vasectrin I (VS I)IBA
04/2012
1Epidermal Growth Factor (EGF)IBA
01/2012
1gefitinib (Iressa)FDA Link
01/2012
1dasatinib (BMS 354825)FDA Link
06/2011
1discoidin receptorIBA
06/2011

Therapy/Procedure

6Drug Therapy (Chemotherapy)
09/2015 - 05/2004
5Chemoprevention
04/2010 - 03/2003
2Heterologous Transplantation (Xenotransplantation)
04/2013 - 06/2011
1Immunomodulation
01/2015
1Radiotherapy
03/2014
1Transplants (Transplant)
07/2013
1Replantation
04/2013
1Therapeutics
09/2012
1Individualized Medicine
04/2012
1Adjuvant Chemotherapy
04/2012